Quality of life and cost of illness in patients with psoriasis in Malaysia: A multicenter study

International Journal of Dermatology

Volumn 52, Issue 3, 2013, Pages 314-322

  Tang, Min Moon ^a   Chang, Choong Chor ^a   Chan, Lee Chin ^b   Heng, Agnes ^c  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b HOSPITAL PULAU PINANG   (Malaysia)

^c HOSPITAL RAJA PERMAISURI BAINUN   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONSULTATION; COST OF ILLNESS; DEPRESSION; DERMATOLOGIST; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALAYSIA; MALE; OUTPATIENT; PRESCRIPTION; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84873967779     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05340.x     Document Type: Article

References (25)

1. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 2004; 9: 136-139.
2. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient membership survey. Arch Dermatol 2001; 137: 280-284.
3. Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol 2005; 152: 861-867.
4. Choi J, Koo J. Quality of life issues in psoriasis. J Am Acad Dermatol 2003; 49(Suppl.): 57-61.
5. Schöffski O, Augustin M, Prinz J, et al. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study. J Dtsch Dermatol Ges 2007; 5: 209-218.
6. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995; 34: 702-703.
7. Mckenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol 1997; 36: 388-394.
8. Gelfand JM, Feldman SR, Stern RS, et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-708.
9. Zachariae R, Zachariae H, Blomqvist K, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-1016.
10. Kanikowska A, Kramer L, Pawlaczyk M. Quality of life in Polish patients with psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 70-110.
11. Lim TO, Ding LM, Zaki M, et al. Distribution of body weight, height and body mass index in a national sample of Malaysian adults. Med J Malaysia 2000; 55: 108-128.
12. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67.
13. Herron MD, Hinckley M, Hoffman MS, Papenfuss J. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534.
14. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
15. Mease PJ, Menter A. Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol 2006; 54: 685-704.
16. Krueger G, Papp K, Stough DB, et al. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of two courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 2002; 47: 821-833.
17. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-244.
18. Rapp SR, Feldman SR, Exum L, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407.
19. Javitz HS, Ward MM, Farber E, et al. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol 2002; 46: 850-860.
20. Jenner N, Campbell J, Plunkett A, Marks R. Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol 2002; 43: 255-261.
21. Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exp Dermatol 1987; 12: 8-11.
22. Gupta MA, Gupta AK. The psoriasis life stress inventory: a preliminary index of psoriasis-related stress reactors. Acta Dermatol Venereol (Stockh) 1995; 75: 240-243.
23. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality of life measure for patients with skin disease: reliability, validity and responsiveness. J Invest Dermatol 1996; 107: 707-713.
24. Spiegelhalter DJ, Gore SM, Fitzpatrick R, et al. Quality of life measures in health care. III: resource allocation. BMJ 1992; 305: 1205-1209.
25. Malaysian Medical Fee Act. Revised 2003. (Perintah Fi [Perubatan] [Pindaan] 2003.) PU(A) 6/2003.